Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: John Patterson who wrote (267)	10/23/1998 6:12:00 PM
From: wolfdog2	Respond to of 712

John, thanks for your informative and interesting post. It's nice to hear from someone who is in the field where the product is actually being used. Ken

To: John Patterson who wrote (267)	10/25/1998 2:30:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 712

John, It's always interesting to hear field reports. However, other centers must differ, as ReoPro sales are currently in excess of $100m a quarter, while Integrillin is at around $2m per quarter (although the latter may be at wholesale prices). What's your reaction to the following release, claiming ReoPro- related bleeding events can be reduced to placebo levels with appropriate care? The six-month outcome for ReoPro/stenting look compelling to me - what's your view on this? biz.yahoo.com I'm currently long CNTO, but am open to buying CORR instead/as well. Peter

To: John Patterson who wrote (267)	10/29/1998 8:15:00 PM
From: aknahow	Read Replies (1) \| Respond to of 712

John, a belated thanks for your informative post. While I am responsible for my investment decisions and would not want to burden any other poster with even an implied responsibility, informative post provide something to think about. A poster on Yahoo recommends calling hospitals in ones are to find out what they are doing. I have hesitated to do since I don't quite know how to get connected with someone that would understand and be willing to answer the question. Do you think this is worthwhile? If so, which department should one ask for.